Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.15B |
| 2 |
NVIDIA
NVDA
|
+$4.1B |
| 3 |
Starbucks
SBUX
|
+$3.07B |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.91B |
| 5 |
UnitedHealth
UNH
|
+$1.46B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.5B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.28B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.66B |
| 4 |
GE Aerospace
GE
|
+$1.57B |
| 5 |
PNC Financial Services
PNC
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Healthcare | 17.77% |
| 3 | Consumer Discretionary | 12.89% |
| 4 | Industrials | 11.65% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWIN
276
Baldwin Insurance Group
BWIN
$2.93B
| $114M | 0.02% |
2,546,269
+286,927
| +13% | +$11.7M |
|
277
Black Hills Corp
BKH
$5.64B
| $113M | 0.02% |
1,863,193
+18,105
| +1% | +$1.07M |
|
278
Applied Materials
AMAT
$441B
| $112M | 0.02% |
770,303
+188,714
| +32% | +$31.7M |
|
279
Williams-Sonoma
WSM
$28.9B
| $111M | 0.02% |
700,051
-225,711
| -24% | -$43.6M |
|
280
Patria Investments
PAX
$1.84B
| $111M | 0.02% |
9,794,358
-268,506
| -3% | -$3.13M |
|
281
ICF International
ICFI
$1.59B
| $110M | 0.02% |
1,293,114
+54,219
| +4% | +$5.68M |
|
282
DT Midstream
DTM
$13.8B
| $109M | 0.02% |
1,132,540
+233
| +0% | +$23.3K |
|
283
Levi Strauss
LEVI
$8.61B
| $103M | 0.02% |
6,625,378
| – | – |
|
|
BA.PRA
284
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.14B
| $103M | 0.02% |
1,721,356
-818,644
| -32% | -$48.9M |
|
|
TLN
285
Talen Energy Corp
TLN
$17.2B
| $103M | 0.02% |
514,310
-389,404
| -43% | -$84.5M |
|
286
CONMED
CNMD
$1.48B
| $101M | 0.02% |
1,673,404
+96,232
| +6% | +$6.2M |
|
287
Haemonetics
HAE
$4.15B
| $100M | 0.02% |
1,577,323
-2,661,631
| -63% | -$181M |
|
288
Credo Technology Group
CRDO
$52.8B
| $100M | 0.02% |
2,489,096
-1,386,034
| -36% | -$86.2M |
|
|
AL
289
DELISTED
Air Lease Corp
AL
| $99M | 0.02% |
2,050,000
| – | – |
|
290
Grab
GRAB
$14.8B
| $98.1M | 0.02% |
21,654,855
-420,350
| -2% | -$1.96M |
|
291
FedEx
FDX
$78.6B
| $97.6M | 0.02% |
400,510
-117,504
| -23% | -$30.5M |
|
292
GitLab
GTLB
$6.96B
| $96.4M | 0.02% |
2,050,027
-242,796
| -11% | -$14.8M |
|
|
UMH
293
UMH Properties
UMH
$1.41B
| $94.2M | 0.02% |
5,036,608
+1,004,759
| +25% | +$18.3M |
|
294
Matsons
MATX
$6.47B
| $93.2M | 0.02% |
727,208
-26,206
| -3% | -$3.59M |
|
295
Semtech
SMTC
$13.1B
| $89.4M | 0.02% |
2,599,016
+465,907
| +22% | +$23M |
|
296
SS&C Technologies
SSNC
$18.9B
| $88.9M | 0.02% |
1,063,750
+3,421
| +0.3% | +$283K |
|
297
Autodesk
ADSK
$52.2B
| $88.7M | 0.02% |
338,658
-240,118
| -41% | -$68.3M |
|
298
West Pharmaceutical
WST
$24.7B
| $87.5M | 0.02% |
390,678
+167,468
| +75% | +$46.2M |
|
299
Welltower
WELL
$168B
| $87.3M | 0.02% |
570,000
-108,940
| -16% | -$15.5M |
|
300
Lattice Semiconductor
LSCC
$18.6B
| $87.2M | 0.02% |
1,662,200
-596,300
| -26% | -$35.5M |
|
Similar funds
Capital Research Global Investors's Q1 2025 Portfolio in Review
As of Q1 2025, Capital Research Global Investors held 477 positions worth $460B, down 5.4% from $486B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Capital Research Global Investors's Q1 2025 filing shows 39 new, 191 increased, 187 reduced and 21 closed positions. Its largest new stake was Charter Communications: 1,626,990 shares worth $600M. The largest sale was Apple, an estimated $5.5B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2025 buy was Charter Communications: 1,626,990 shares worth $600M.
- Capital Research Global Investors added most to Eli Lilly in Q1 2025, an estimated $4.15B increase.
- Capital Research Global Investors's biggest Q1 2025 reduction was Apple, cutting an estimated $5.5B.
- Capital Research Global Investors fully exited East-West Bancorp in Q1 2025, selling an estimated $410M.
- Capital Research Global Investors's ten largest holdings make up 31% of its $460B portfolio in Q1 2025.
- Capital Research Global Investors opened 39 new positions and closed 21 in Q1 2025.
- Capital Research Global Investors's portfolio value fell 5.4% quarter-over-quarter to $460B.
Based on Capital Research Global Investors's 13F filing for Q1 2025, filed 12 May 2025.